ACS CAN Comments on Importation proposed rule

March 14, 2020

On Monday, March 9, 2020, ACS CAN filed comments in response to HHS' proposed rule to implement a prescription drug importation program. While we commended the Administration for examining ways to tackle the problem of prescription drug affordability, our comments expressed concern that the proposal as outlined raises a number of serious questions about the administrative feasibility, safety and actual savings for consumers.